Cryosite (Australia) Today
| CTE Stock | 1.01 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressLow
|
Cryosite is selling for under 1.01 as of the 19th of January 2026; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.01. Cryosite has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of October 2025 and ending today, the 19th of January 2026. Click here to learn more.
Moving against Cryosite Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cryosite Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cryosite's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cryosite or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cryosite (CTE) is traded on Australian Securities Exchange in Australia and employs 25 people. Cryosite is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cryosite's market, we take the total number of its shares issued and multiply it by Cryosite's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cryosite operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 48.81 M outstanding shares.
Cryosite has accumulated about 0 in cash with 2.06 M of positive cash flow from operations.
Check Cryosite Probability Of Bankruptcy
Ownership AllocationCryosite holds a total of 48.81 Million outstanding shares. Cryosite shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.43 percent of Cryosite outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cryosite Ownership Details
Cryosite Risk Profiles
Although Cryosite's alpha and beta are two of the key measurements used to evaluate Cryosite's performance over the market, the standard measures of volatility play an important role as well.
Cryosite Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cryosite without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Cryosite Corporate Management
Elected by the shareholders, the Cryosite's board of directors comprises two types of representatives: Cryosite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryosite. The board's role is to monitor Cryosite's management team and ensure that shareholders' interests are well served. Cryosite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryosite's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Hogg | Chief Officer | Profile | |
| Hamish George | Company Secretary | Profile | |
| Jane Hao | Chief Officer | Profile | |
| Jon Stearns | Operations Manager | Profile | |
| BCom CPA | Company Sec | Profile | |
| Dray Andrea | Company Secretary | Profile |
Additional Tools for Cryosite Stock Analysis
When running Cryosite's price analysis, check to measure Cryosite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryosite is operating at the current time. Most of Cryosite's value examination focuses on studying past and present price action to predict the probability of Cryosite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryosite's price. Additionally, you may evaluate how the addition of Cryosite to your portfolios can decrease your overall portfolio volatility.